Search for a research project
Other search option(s)
30 Result(s)
Funded by an IRDiRC member = 
Research projects
CANADA
Québec
MONTRÉAL
Function of Parkinson Disease Genes in Mitochondrial Quality Control
Montreal Neurological Institute and Hospital
Fon Lab
CANADA
Québec
MONTRÉAL
Function of Parkinson Disease Role of PINK1 Processing in Mitochondrial Function and Parkinson's Disease
Montreal Neurological Institute and Hospital
Fon Lab
FRANCE
ILE-DE-FRANCE
PARIS
Selection and multicenter longitudinal prospective study of a cohort in non-idiopathic parkinson syndrome
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Service de pharmacologie médicale - Unité Pharmacologie Clinique
FRANCE
ILE-DE-FRANCE
PARIS
Development of therapeutic strategies for human degenerative diseases
Centre Paul Broca
Biologie et pathologie du neurone
GERMANY
Baden-Württemberg
TÜBINGEN
LRRK2 as a target for the treatment of Parkinson's disease
Hertie-Institut für klinische Hirnforschung (HIH)
Abteilung Neurologie mit Schwerpunkt neurodegenerative Erkrankungen
GERMANY
Baden-Württemberg
TÜBINGEN
Characterization and behavioural consequences of alpha-Synucleinopathies in transgenic mice
Hertie-Institut für klinische Hirnforschung (HIH)
Abteilung für Neurodegeneration - Funktionelle Neurogenetik
ITALY
LOMBARDIA
MILANO
Analysis of neuronal alterations associated to PARK2 mutations and their rescue by genetic and pharmacological therapies targeting kainate receptors
IRCCS Istituto Auxologico Italiano - Ospedale San Luca
Laboratorio Neuroscienze
ITALY
TRENTINO ALTO ADIGE
TRENTO
Parkinson's disease at the synaptic site: short and long term impact of pathological LRRK2 kinase activity
Università di Trento
Laboratory of Biology of Synapses
JAPAN
JAPAN
ADDRESS : NOT PROVIDED - JP
Development of diagnostic system for Parkinson's disease using faty acid metabolites
Institution: Information not provided - JP
JAPAN
JAPAN
HYOGO
Next-generation treatment strategy of Parkinson's disease by Precision Medicine
Kobe University Graduate School of Medicine
Division of Neurology/Molecular Brain Science
JAPAN
JAPAN
OSAKA
Novel therapeutic challenge for Parkinson disease accompanied by mutations of alpha-synuclein.
Osaka City University Graduate School of Medicine and Faculty of Medicine
Genetic Disease Research
JAPAN
JAPAN
TOKYO
Drug Screening for Parkinson's disease using patient-specific iPSCs.
Juntendo University School of Medicine
Center for Genomic and Regenerative Medicine
PORTUGAL
NORTE
PORTO
Clinical implications of genetic factors causing neurodegenerative diseases characterized by movement or cognitive dysfunction.
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas
SPAIN
Madrid
MADRID
RAREGenomics: Network of Genomic, Functional, Clinical and Therapeutic Resources for the Study of Rare Neurological Diseases
Hospital Universitario Fundación Jiménez Díaz
Servicio de Genética Clínica
FRANCE
ILE-DE-FRANCE
PARIS
STaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy - FR
Muséum National d'Histoire Naturelle
Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196
FRANCE
PAYS DE LA LOIRE
NANTES
FROGH : FRench Regional Origins in Genetics for Health - FR
Institut de Recherche en Santé - Université de Nantes
L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291
ITALY
CAMPANIA
NAPOLI
Telethon Undiagnosed Disease Program - Revised Proposal
TIGEM - Telethon Institute of Genetics and Medicine
Genomic Medicine - Telethon Institute of Genetics and Medicine
JAPAN
JAPAN
AICHI
Management ofthe clinical diagnostic centre for rare intractable diseases with genome instability and development of potential therapeutic medicine
Research Institute of Environmental Medicine, Nagoya University
JAPAN
JAPAN
AICHI
Establishment of the Next-generation Muti-omics Clinical Diagnostic Centre for rare intractable diseases with genome instability
Research Institute of Environmental Medicine, Nagoya University
JAPAN
JAPAN
TOKYO
Formation of integrated omics analysis base of refractory diseases in children and perinatal period
National Center for Child Health and Development
Research Institute
Multicentric Research projects
- Hertie-Institut für klinische Hirnforschung (HIH)
- Abteilung Neurologie mit Schwerpunkt neurodegenerative Erkrankungen
- Institut für Medizinische Genetik und angewandte Genomik Tübingen
- Institut für Medizinische Genetik und angewandte Genomik
- Institut für Medizinische Genetik und angewandte Genomik Tübingen
- Institut für Medizinische Genetik und angewandte Genomik
- Hertie-Institut für klinische Hirnforschung (HIH)
- Abteilung Neurologie mit Schwerpunkt neurodegenerative Erkrankungen
- Zentrum für Neuropathologie und Prionforschung (ZNP)
- Zentrum für Neuropathologie und Prionforschung der LMU München
- Hospital Universitari de Bellvitge
- Unidad de Neuropatología
- University of British Columbia
- Maternal Infant Child and Youth Research Network
- Muséum National d'Histoire Naturelle
- Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196
- Institut de Recherche en Santé - Université de Nantes
- L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291
- IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
- Servizio Clinico di Consulenza Genetica
GERMANY
Baden-Württemberg
TÜBINGEN
MEFOPA: European project on mendelian forms of Parkinson's disease (Terminated)
GERMANY
Baden-Württemberg
TÜBINGEN
RATSTREAM: European project on the characterisation of transgenic rat models for neurodegenerative and psychiatric diseases: Automated home cage analyses, live imaging and treatment (FINISHED)
GERMANY
Baden-Württemberg
TÜBINGEN
NEURASYNC: Academic-Industrial Training Network on Alpha-Synuclein-related Brain Diseases
GERMANY
Baden-Württemberg
TÜBINGEN
NGFN plus: IG Functional Genomics of Parkinson's disease -terminated
GERMANY
Bayern
MÜNCHEN
BNE: BrainNet Europe II: European brain tissue bank
SPAIN
Cataluña
L'HOSPITALET DE LLOBREGAT
CIEN: Spanish Network for Cooperative Research in Neurological diseases
CANADA
Colombie-Britannique
VANCOUVER
Maternal Infant Child and Youth Research Network (MICYRN)
FRANCE
ILE-DE-FRANCE
PARIS
STaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy
FRANCE
PAYS DE LA LOIRE
NANTES
FROGH : FRench Regional Origins in Genetics for Health
ITALY
LAZIO
ROMA